For research use only. Not for human or animal consumption.
What it is
SS-31 is a synthetic tetrapeptide — four amino acid residues, amidated at the C-terminus. The literature and supplier catalogues index the same free base under more than one name, including MTP-131 and “Szeto–Schiller peptide”. Two listings under different names are not necessarily two different materials.
The published sequence is D-Arg-Dmt-Lys-Phe-NH2, in which Dmt is 2′,6′-dimethyltyrosine, a non-proteinogenic residue. The alternating basic and aromatic arrangement is the structural motif the primary literature uses to define the class [1][2].
The identity block a vial and its certificate should match:
- Chemical name: SS-31 (MTP-131)
- CAS number: 736992-21-5
- Molecular formula: C32H49N9O5
- Molecular weight: 639.80 (free base)
- PubChem CID: 11764719
- Form: lyophilised powder
- Storage: −20°C, desiccated, protected from light
Clarion supplies the material as a lyophilised powder; the receiving laboratory dissolves the powder at its own discretion. The published release specification is >99% by HPLC main peak, with identity confirmed by mass spectrometry.
How to verify a vial before you pay
1. A named third-party laboratory. The certificate for Clarion’s last SS-31 lot, 2S10 (now sold out), was issued by Freedom Diagnostics Testing, with Clarion Peptides named as the client. Our lots carry reports from two named outside laboratories: Freedom Diagnostics reports that we ordered, and Janoshik reports that our supplier ordered. So the laboratory, and who ordered the test, are read off that lot’s own certificate rather than assumed from the brand. Each lot with a finished report in the public lot ledger links to that lot’s certificate. An unnamed laboratory is not verification.
2. An identity method that reads sequence, not just mass. This is the sharp edge for this molecule. SS-31 is D-Arg-Dmt-Lys-Phe-NH2. A closely related Szeto–Schiller tetrapeptide, Dmt-D-Arg-Phe-Lys-NH2 — indexed as [Dmt1]DALDA, PubChem CID 9809562, CAS 255861-98-4 — contains the same four residues in a different order, and therefore carries the identical formula, C32H49N9O5, and the identical 639.8 average mass. Two registry numbers, one mass. It is not a near neighbour either: the literature characterises it as a high-potency opioid-receptor ligand [4]. Identity here is a sequence question, answered by MS/MS fragmentation that reads residue order or by retention-time co-elution against an authentic reference standard — not by an area percentage beside a single parent-ion mass.
3. A printed method and figure. HPLC main-peak purity against a stated release specification (Clarion publishes >99%) and mass-spec identity confirmation, with the numbers on the page rather than the word “tested”.
What a certificate usually does not settle: net peptide content. The 639.80 figure is the free base. The registered hydrochloride form is C32H52Cl3N9O5 at 749.2 (PubChem CID 137528200) — roughly 17% heavier for the same number of peptide molecules, reflecting three basic sites: the guanidine, the lysine amine and the N-terminus. Trifluoroacetate counterions carried over from preparative HPLC purification are heavier still, and residual water adds more. A milligram figure on a vial is therefore a gross powder weight unless a certificate states net peptide content, and main-peak area says nothing about counterion identity, counterion load or moisture. That is the question to put to any supplier before prices per milligram are compared.
And the non-standard residue. Dmt is the harder and more expensive part of the synthesis. Ordinary tyrosine in its place yields a different tetrapeptide, two methylene groups lighter; the eLife work characterised exactly such an analog alongside SS-31 [3]. Unlike the sequence isomer, that substitution is visible on an accurate mass readout — which is why the mass figure is worth reading rather than skimming. An incompletely amidated free-acid impurity is the quieter version of the same failure: about one mass unit apart, resolvable only at high mass resolution.
The SS-31 buying guide covers the five checks to run on any seller’s SS-31, including ours.
Common questions
What is SS-31, in one line? A synthetic, C-terminally amidated aromatic-cationic tetrapeptide (CAS 736992-21-5, C32H49N9O5, 639.80 free base), supplied as a lyophilised powder for research use only.
Is it a mitochondria-derived peptide like MOTS-c? No. It is a fully synthetic tetrapeptide with a designed motif, not a peptide encoded in mitochondrial DNA. Other SS-series analogs, SS-20 among them, share the family name and the motif without sharing the sequence.
Why is a mass number alone not enough? Because a sequence isomer, [Dmt1]DALDA, carries the identical formula and average mass under a different registry number [4].
How should it be stored? At −20°C, desiccated and protected from light.
Is this a medicine? No. It is research-use-only material, not for human or animal consumption.
References
Titles are omitted deliberately. Every record was confirmed against PubMed on 2026-08-20.
- Zhao K, Zhao GM, Wu D, et al. J Biol Chem. 2004;279(33):34682–34690. PMID 15178689; DOI 10.1074/jbc.M402999200.
- Mitchell W, Ng EA, Tamucci JD, et al. J Biol Chem. 2020;295(21):7452–7469. PMID 32273339; DOI 10.1074/jbc.RA119.012094.
- Mitchell W, Tamucci JD, Ng EL, et al. eLife. 2022;11. PMID 35913044; DOI 10.7554/eLife.75531.
- Neilan CL, Janvey AJ, Bolan E, et al. J Pharmacol Exp Ther. 2003;306(2):430–436. PMID 12663687; DOI 10.1124/jpet.103.049742.
Chemistry cross-checked against PubChem CID 11764719, CID 9809562 and CID 137528200.
Related: How to verify a peptide certificate of analysis.
SS-31 (MTP-131), CAS 736992-21-5, C32H49N9O5, 639.80 free base. Release specification >99% HPLC main peak, identity by mass spectrometry. For research use only. Not for human or animal consumption. Not a drug.
